Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.
Press releases published on May 2, 2025

Vital Battery Metals Announces Name Change to Aventis Energy
VANCOUVER, British Columbia, May 02, 2025 (GLOBE NEWSWIRE) -- Vital Battery Metals Inc. (“Vital” or the “Company”) (CSE: VBAM | OTC: VBAMF | FRA: C0O), is pleased to announce that the Company’s Board of Directors have approved a name change to “Aventis …

XCEL BRANDS, INC. Receives NASDAQ notice regarding late Form 10-K filing
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), today announced that on April 29, 2025, it received a delinquency notification letter from the Nasdaq Stock Market LLC ("Nasdaq") indicating that the …

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …

Beyond Oil Expands to Greece with New Distribution Agreement
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, May 02, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) ("Beyond Oil" or the "Company"), a food-tech innovation company dedicated to reducing health risks associated with fried …

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO Calif. and SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that …

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, May 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …

dvm360® unveils 2025–2026 Editorial Advisory Board: Fresh perspectives spark innovation across the veterinary field
CRANBURY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- dvm360®, the leading multimedia provider of animal health care communications, education and research for veterinary professionals, is thrilled to announce its 2025–2026 Editorial Advisory Board, featuring …

Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 1Q25
Lima, May 02, 2025 (GLOBE NEWSWIRE) -- Lima, PERU, April, May 2nd, 2025 – Credicorp Ltd. announces to its shareholders and the market that its 1Q25 Earnings Release Report will be released on Thursday, May 15th, 2025, after market close. Credicorp’s …

NXP Announces Availability of Proxy Materials for the Annual General Meeting of Shareholders to Be Held on June 11, 2025
EINDHOVEN, The Netherlands, May 02, 2025 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) will hold its annual meeting of shareholders on Wednesday, June 11, 2025 at 08.45 a.m. CET at the Sheraton Amsterdam Airport Hotel and Conference Center, …

Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications
XI’AN, China, May 02, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that on April 29, …

XRP News: Buy $XDX Tokens Now Before XenDex Presale Ends Soon, as XRP Market Heats Up
SYDNEY, May 02, 2025 (GLOBE NEWSWIRE) -- As excitement grips the XRP community following recent breakthroughs including ProShares’ XRP Futures ETF approval, Brazil’s XRP Spot ETF rollout, and the SEC’s lawsuit withdrawal, all eyes are now on XenDex, the …

Update on Market Making Arrangements
Reykjavík, May 02, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) Update on Market Making Arrangements TORONTO, ONTARIO – May 02, 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mining company with a …

PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
MIAMI, May 02, 2025 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) declares its monthly distribution for May 2025 of $0.08 per share, payable on June 2, 2025 to stockholders of record as of May 15, 2025. The …

Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025
BOCA RATON, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first …

PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
MIAMI, May 02, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) declares its monthly distribution for May 2025 of $0.1025 per share, payable on June 2, 2025 to stockholders of record as of May 15, 2025. The …

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2025 the Company granted inducement awards to purchase up …

Taitron Announces Quarterly Cash Dividend
LOS ANGELES, May 02, 2025 (GLOBE NEWSWIRE) -- Taitron Components Incorporated (NASDAQ:TAIT) today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share of common stock, payable on May 30, 2025 to stockholders of …

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BOSTON , May 02, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on April 30, 2025, the company granted equity awards to seven new employees, …

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …